Tumasian K S, Akopov S E, Gabrielian E S
Farmakol Toksikol. 1988 Sep-Oct;51(5):49-53.
Beta-adrenoblockers were found to be able of suppressing platelet aggregation through beta 2-subtype of adrenoreceptors. This is due to the membrane-stabilizing action of beta-adrenoblockers which by binding to the receptors decrease microviscosity of the membranes and prevent the opposite shift under the influence of aggregation inductors.